行业背景， According to data presented by CBRE Research (CBRE), Life Sciences Venture Capital funding has declined from over $30 billion annually in 2021 to a low of ~$17 billion in 2023.

$丹纳赫(DHR)$ 生命科学分析，诊断设备制造和服务提供商。垄断双子星，盘前发布业绩带动$赛默飞世尔科技(TMO)$ 。一季度营收5.8 billion usd, 同比下降2%。营收下降减慢。预计全年营收同比下降5%以内。一季度经营性现金流1.7 billion, 略超预期。